Crossref
Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects
International Journal of Drug Delivery Technology · 28.07.2026 · 16 (70s)
DOI: 10.25258/ijddt.16.70s.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 28.07.2026. Verfasst von Anil Malleshappa und 1 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Malleshappa, A., & Katageri, K. (2026). Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects. International Journal of Drug Delivery Technology, 16(70s). https://doi.org/10.25258/ijddt.16.70s.29
Vancouver
Malleshappa A, Katageri K. Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects. International Journal of Drug Delivery Technology. 2026;16(70s). doi:10.25258/ijddt.16.70s.29
BibTeX
@article{Malleshappa2026,
author = {Malleshappa, Anil and Katageri, Krutika},
title = {Nanotechnology-Enabled Drug Delivery for Cancer Immunotherapy: Current Progress and Future Prospects},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {70s},
doi = {10.25258/ijddt.16.70s.29}
}
EUVIMED